WRBY
HealthcareWarby Parker Inc. · Medical - Instruments & Supplies · $3B
What is Warby Parker Inc.?
Warby Parker is a consumer-facing eyewear brand that sells prescription glasses, sunglasses, and contact lenses through its own retail stores, website, and mobile apps. The company also provides eye exams directly to customers at its physical locations.
Warby Parker sells eyewear directly to consumers, cutting out traditional optical retail middlemen. Revenue comes from eyeglasses, sunglasses, specialty lenses, contact lenses, and accessories sold online and in company-owned stores. The brand also generates revenue from in-store eye exams and vision tests, creating a vertically integrated experience that combines retail and basic healthcare services under one roof.
Incorporated in 2009 and headquartered in New York City, Warby Parker operates across the United States and Canada.
- Prescription eyeglasses and sunglasses
- Light-responsive and blue-light-filtering lenses
- Contact lenses
- In-store eye exams and vision tests
- Eyewear accessories including cases and anti-fog sprays
Is WRBY a Good Stock to Buy?
UQS Score rates WRBY as Below Average overall.
The Growth pillar stands out as a relative bright spot, reflecting Warby Parker's ongoing store expansion and rising consumer adoption of its direct-to-consumer model. The Risk pillar also registers as Good, suggesting the company's near-term financial risk profile is manageable relative to peers.
The Quality and Moat pillars both register as Weak, pointing to thin competitive defenses and profitability challenges that are common in early-stage retail healthcare businesses. Valuation is flagged as Elevated, meaning the market may already be pricing in optimistic outcomes.
Pro members can view the complete pillar breakdown and underlying financial metrics behind WRBY's UQS Score. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does WRBY pay dividends?
No — Warby Parker Inc. does not currently pay a dividend.
Warby Parker does not currently pay a dividend. As a growth-oriented retailer still investing heavily in store expansion and technology, the company reinvests available capital into the business rather than returning cash to shareholders. Income-focused investors should factor this into their assessment.
When does WRBY report earnings?
Warby Parker reports earnings on a quarterly cadence, typical for US-listed equities.
Each quarterly report tends to focus on store count growth, comparable sales trends, and the path toward sustainable profitability — themes central to how the market evaluates WRBY. Results have historically reflected the tension between top-line expansion and ongoing investment in infrastructure.
For the most recent quarter's results, visit Warby Parker's investor relations page directly.
WRBY Price History
-52.6% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Warby Parker Inc.?
Based on Warby Parker Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
WRBY Long-term Outlook
Warby Parker's fundamental outlook is shaped by its Good Growth profile, which reflects continued retail expansion and a growing customer base. However, the Weak Quality and Moat pillars suggest that converting growth into durable profits remains a challenge. The Elevated Valuation pillar indicates that much of the growth story may already be reflected in the current share price, leaving limited margin for execution missteps.
Growth drivers
- Continued expansion of company-owned retail store footprint across North America
- Cross-selling of eye exams and contact lenses alongside core eyewear products
- Growing direct-to-consumer digital channel and mobile app engagement
Key risks
- Sustained profitability pressure given Weak Quality and Moat pillar ratings
- Elevated valuation leaves little room for growth disappointments
- Competitive intensity from both traditional optical retailers and online eyewear brands
WRBY vs Peers
Within the Healthcare sector, WRBY is sometimes grouped alongside other mid-cap medical and specialty product companies.
Haemonetics focuses on blood management technology and hospital supply chains, operating in a more specialized and recurring-revenue segment of healthcare.
ICU Medical makes infusion therapy and critical care products, serving hospitals rather than direct consumers — a fundamentally different business model from Warby Parker.
LeMaitre Vascular develops devices for vascular surgery, competing in a niche medical device market with a different customer base and margin profile than consumer eyewear.
Frequently Asked Questions
What does Warby Parker do?
Warby Parker sells eyeglasses, sunglasses, contact lenses, and specialty lenses directly to consumers through its own retail stores, website, and mobile app. The company also offers eye exams at its physical locations, combining retail and basic vision care under one brand.
Does WRBY pay dividends?
No, Warby Parker does not currently pay a dividend. The company is in a growth phase and reinvests capital into store expansion and technology rather than distributing cash to shareholders.
When does WRBY report earnings?
Warby Parker reports on a standard quarterly cadence. For exact dates and the most recent results, check the investor relations section of the company's official website.
Is WRBY a good stock to buy?
UQS Score rates WRBY as Below Average, reflecting Weak Quality and Moat pillars alongside an Elevated Valuation. The Growth and Risk pillars are more favorable. Whether it fits your portfolio depends on your risk tolerance and time horizon — the full pillar breakdown is available to Pro members.
Is WRBY overvalued?
The UQS Valuation pillar for WRBY is rated Elevated, suggesting the current market price may already incorporate optimistic growth expectations. This does not guarantee the stock will fall, but it does indicate limited valuation cushion relative to sector peers.
How does WRBY compare to its competitors?
Warby Parker's sector peers on UQS Score include Haemonetics, ICU Medical, and LeMaitre Vascular — all of which operate in medical devices or hospital supply rather than consumer retail. WRBY's direct-to-consumer model and retail footprint make it a distinct business within the broader Healthcare classification.
What is WRBY's market cap bracket?
Warby Parker is classified as a mid-cap company. This places it in a range where growth potential remains meaningful but institutional coverage and liquidity are generally more established than for small- or micro-cap peers.
Who founded Warby Parker?
Warby Parker was founded in 2010 by Neil Blumenthal, Dave Gilboa, Andrew Hunt, and Jeffrey Raider while they were students at the Wharton School. The company was incorporated under the name JAND, Inc. before rebranding to Warby Parker Inc. in 2021.
Is WRBY a long-term quality investment?
From a long-term quality perspective, WRBY's Weak Moat pillar raises questions about whether the brand can sustain a durable competitive advantage over time. The Growth pillar is encouraging, but long-term quality investing typically favors companies with stronger moats and profitability foundations.
What is the main competitive advantage of Warby Parker?
Warby Parker's primary advantage is its vertically integrated direct-to-consumer model, which allows it to control pricing, branding, and the customer experience from manufacturing to point of sale. However, the UQS Moat pillar rates this advantage as Weak relative to sector peers, suggesting it remains difficult to defend.
What sector does WRBY belong to?
Warby Parker is classified under the Healthcare sector. While it operates primarily as a consumer retail brand, its vision care services and optical health products place it within healthcare classifications used by major index providers.
Is WRBY a growth stock or value stock?
Based on its UQS pillar profile, WRBY leans toward the growth category — the Growth pillar is rated Good while the Valuation pillar is Elevated, a combination more typical of growth-oriented names than value plays.
Unlock Full WRBY Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS Score and all five pillar ratings
- ✓Access underlying financial metrics driving each pillar
- ✓Compare WRBY against sector peers side by side
- ✓Screen for stocks with stronger Quality and Moat profiles
- ✓Get the complete analyst-style view in one dashboard
Pro Analysis
WRBY — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | 42.0 | 19.7 | 23.0 | 78.5 | 71.5 | 32.7 | +0.2 |
| May 17, 2026 | 41.8 | 19.3 | 23.0 | 78.5 | 71.5 | 31.6 | -0.6 |
| May 7, 2026 | 42.4 | 20.5 | 23.0 | 78.4 | 71.7 | 33.8 | +0.1 |
| May 5, 2026 | 42.3 | 20.5 | 23.0 | 78.4 | 71.7 | 33.4 | 0.0 |
| May 3, 2026 | 42.3 | 20.5 | 23.0 | 78.4 | 71.7 | 33.5 | 0.0 |
| Apr 26, 2026 | 42.3 | 20.5 | 23.0 | 78.4 | 71.7 | 33.6 | +0.1 |
| Apr 19, 2026 | 42.2 | 20.5 | 23.0 | 78.4 | 71.7 | 32.8 | -0.2 |
| Apr 18, 2026 | 42.4 | 20.5 | 23.0 | 78.4 | 71.7 | 34.2 | -1.3 |
| Apr 14, 2026 | 43.7 | 20.5 | 23.0 | 78.4 | 71.7 | 42.7 | 0.0 |
| Apr 12, 2026 | 43.7 | 20.5 | 23.0 | 78.4 | 71.7 | 42.9 | -0.1 |
WRBY — Pillar Breakdown
Quality
— 19.7/100 (25%)Warby Parker Inc. currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 78.5/100 (20%)Warby Parker Inc. is growing rapidly with strong revenue and earnings expansion.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 71.5/100 (15%)Warby Parker Inc. maintains a reasonable risk profile with manageable debt levels.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 32.6/100 (15%)Warby Parker Inc. appears expensively valued relative to its fundamentals and growth prospects.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 23/100 (25%)Warby Parker Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for WRBY.
Score Composition
Financial Data
More Stock Analysis
How is the WRBY UQS Score Calculated?
The UQS (Unified Quality Score) for Warby Parker Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Warby Parker Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Warby Parker Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.